STOCK TITAN

Sensus Healthcare director buys 64.8K shares

Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported open-market purchases of the company’s Common Stock.

(Moderate)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported open-market purchases of the company’s Common Stock. On 2026-08-31, he purchased 27,304 shares at $3.538 per share, and on 2026-08-28, he purchased 37,537 shares at $3.437 per share, for a total of 64,841 shares acquired. The filing also lists an indirect holding of 2,093 shares held through his spouse as of 2026-08-28.

Positive

  • None.

Negative

  • None.
Insider Sachetta Eric
Role Director
Bought 64,841 shs ($226K)
Type Security Shares Price Value
Purchase Common Stock 27,304 $3.538 $97K
Purchase Common Stock 37,537 $3.437 $129K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 294,784 shares (Direct); Common Stock — 2,093 shares (Indirect, Spouse)
Shares purchased on 2026-08-31 27,304 shares of Common Stock Open-market or private purchase by director Eric Sachetta at $3.538 per share
Purchase price on 2026-08-31 $3.538 per share Price paid for 27,304 Sensus Healthcare Common Stock shares
Shares purchased on 2026-08-28 37,537 shares of Common Stock Open-market or private purchase by director Eric Sachetta at $3.437 per share
Purchase price on 2026-08-28 $3.437 per share Price paid for 37,537 Sensus Healthcare Common Stock shares
Total shares purchased in reported transactions 64,841 shares of Common Stock Sum of shares acquired on 2026-08-28 and 2026-08-31
Indirectly held shares via spouse 2,093 shares of Common Stock Indirect ownership reported as held by spouse as of 2026-08-28
Form 4 regulatory
"In this Form 4, Eric Sachetta reported purchasing a total of 64,841 shares"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Common Stock financial
"purchased 27,304 shares of Sensus Healthcare Common Stock at a price"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
indirect holding financial
"The filing also lists an indirect holding of 2,093 shares held"
open-market or private transaction financial
"at a price of $3.538 per share in an open-market or private transaction"

FAQ

What insider transactions were reported for SRTS by Eric Sachetta?

Director Eric Sachetta reported two open-market purchases of Sensus Healthcare Common Stock, totaling 64,841 shares acquired on 2026-08-28 and 2026-08-31 at prices between $3.437 and $3.538 per share.

How many Sensus Healthcare (SRTS) shares did Eric Sachetta buy on 2026-08-31?

On 2026-08-31, Eric Sachetta purchased 27,304 shares of Sensus Healthcare Common Stock at a price of $3.538 per share in an open-market or private transaction.

What SRTS share purchase did Eric Sachetta report on 2026-08-28?

On 2026-08-28, Eric Sachetta purchased 37,537 shares of Sensus Healthcare Common Stock at a price of $3.437 per share in an open-market or private transaction.

What is the total number of SRTS shares Eric Sachetta purchased in this Form 4?

In this Form 4, Eric Sachetta reported purchasing a total of 64,841 shares of Sensus Healthcare Common Stock across transactions on 2026-08-28 and 2026-08-31.

Does Eric Sachetta report any indirect ownership of SRTS shares?

Yes. The Form 4 reports an indirect holding of 2,093 shares of Sensus Healthcare Common Stock, held through his spouse, as of 2026-08-28.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sachetta Eric

(Last)(First)(Middle)
851 BROKEN SOUND PARKWAY NW #215

(Street)
BOCA RATON FLORIDA 33487

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/28/2026P37,537A$3.437267,480D
Common Stock08/31/2026P27,304A$3.538294,784D
Common Stock2,093ISpouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Eric Sachetta08/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)